StockData
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31

CVS HEALTH Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$92.68+0.32 (+0.35%)

Close on Oct 19, 2026

Market cap
$119.28B
P/E (TTM)
24.6
Dividend yield
2.87%

About Cvs Health

Retail-Drug Stores and Proprietary Stores, SIC 5912

CVS Health Corporation is a diversified healthcare solutions enterprise providing health insurance, pharmacy services, and medical care delivery. The company conducts business through four reportable segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. Through its Aetna operations, CVS Health offers commercial, Medicare Advantage, Medicare Part D prescription drug, and Medicaid health plans, alongside dental, behavioral health, and supplemental coverage. Through its CVS Caremark operations, the organization administers pharmacy benefit management solutions, including plan design, formulary oversight, and specialty and mail-order dispensing. Its customers encompass individual health plan members, employer groups, labor unions, commercial health plans, government programs, healthcare providers, and patients receiving care directly.

The company operates approximately 9,000 retail locations and more than 1,000 walk-in and primary care medical clinics across the United States. Its commercial and government health benefit products operate nationwide across U.S. states and Washington, D.C., and serve select members internationally. Additionally, CVS Health manages a pharmacy network comprising approximately 63,000 retail pharmacies throughout the United States, Puerto Rico, Guam, and the U.S. Virgin Islands. The provided text does not state the company's headquarters location.

Summary of the business section of Cvs Health's latest annual report, written by StockData.

Company profile

Company

Legal name
CVS HEALTH Corp
Founded
1963
Headquarters
Woonsocket, RI
Address
One Cvs Dr. 02895
Phone
(401) 765-1500
Employees
300,000, Dec 31, 2025
Industry
Retail-Drug Stores and Proprietary Stores
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, Boston, Massachusetts

Stock & identifiers

Ticker
CVS
Exchange
NYSE
Shares outstanding
1.28B, Jul 29, 2026
Public float
$86.38B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, Jun 7, 2005; 2-for-1, Jun 16, 1998; 2-for-1, Mar 15, 1989; 2-for-1, May 3, 1983
SEC CIK
64803
CUSIP
126650100
ISIN
US1266501006
LEI
549300EJG376EN5NQE29
EIN
05-0494040

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
J. David JoynerPresident, CEO and Chair, Director70,349
James David ClarkSVP, Cont & Chief Acct Officer27,606
Amy Compton-PhillipsEVP, Chief Medical Officer9,592
Brian NewmanEVP, Chief Financial Officer3,038
Tilak MandadiEVP, Chief Exp & Tech Officer10,133
Prem S. ShahEVP and Group President64,356
Steven H. NelsonEVP and President, Aetna2,924
Samrat S. KhichiEVP, CPO and General Counsel33,421
Heidi B. CapozziEVP and Chief People Officer13,108
Thomas F. CowheyEVP and CFO41,109
Fernando AguirreDirector11,181
Larry RobbinsDirector4,824,799
C. David Brown IiDirector129,316
J. Scott KirbyDirector14,434
Guy P. SansoneDirector15,106
John E. GallinaDirector582
Michael F. MahoneyDirector6,555
Leslie V. NorwalkDirector7,376
Anne A. FinucaneDirector22,747
Alecia A. DecoudreauxDirector2,970
Douglas H. ShulmanDirector5,929
Jeffrey R. BalserDirector15,717
Roger N. FarahDirector19,438
Nancy Ann DeparleDirector34,169
Mary L. SchapiroDirector11,844

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
JDavid Joyner
$21.21M$50.48M$10.42M$137$148
FY2024
JDavid Joyner
$17.81M$4.81M$9.78M$74$129
FY2024
Karen SLynch
$23.43M-$15.06M$9.78M$74$129
FY2023
Karen SLynch
$21.62M$7.50M$9.28M$125$126
FY2022
Karen SLynch
$21.32M$23.77M$12.16M$143$124
FY2022
PEO1
$21.32M$23.77M$12.16M$143$124

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“With a talented and diverse workforce of more than 300,000 colleagues, we uphold the highest standards of ethics and transparency while creating value and delivering on our promises.”

Corporate history

Events identified from SEC filings

DateEventDetails
Nov 28, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 4, 2018MergerRegistration of securities for a merger or exchange offer (S-4)
Apr 22, 2016MergerRegistration of securities for a merger or exchange offer (S-4)
Aug 18, 2015Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Sep 3, 2014Name changeName changed from CVS CAREMARK CORP to CVS/CAREMARK CORP
Oct 1, 2007Auditor changeChange in certifying accountant (8-K Item 4.01)
May 8, 2007Name changeName changed from CVS/CAREMARK CORP to CVS HEALTH Corp
Mar 23, 2007Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 22, 2007Name changeName changed from CVS CORP to CVS CAREMARK CORP
Dec 19, 2006MergerRegistration of securities for a merger or exchange offer (S-4)
Aug 8, 2006Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jun 2, 2006Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 13, 2004Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Sep 15, 2004MergerRegistration of securities for a merger or exchange offer (S-4)
Jan 31, 2003MergerRegistration of securities for a merger or exchange offer (S-4)
May 18, 2001MergerRegistration of securities for a merger or exchange offer (S-4)
May 11, 1999MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 2, 1998MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 28, 1997MergerRegistration of securities for a merger or exchange offer (S-4)
Jan 10, 1997Name changeName changed from MELVILLE CORP to CVS CORP